KLINSKY STEVEN B
Follow13F filer, CIK 1018327, New York, NY
KLINSKY STEVEN B reported $219,476,000 across 3 holdings for the quarter ended 2015-03-31, in a 13F-HR filed 2015-05-15.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-15-001220
Changes against Q4 2014 are not shown: its report omitted holdings under a confidential treatment request (2 positions on file), so every position would read as new.
The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.
- Period
- 2015-03-31
- Reported value
- $219M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q1 2015
Share positions as resolved from 13F-HR 0001172661-15-001220, largest first. % of portfolio is the value over $219,476,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| EVERBANK FINANCIAL CORPORAT…EVERBANK FINANCIAL CORPORATION | 6,989,683 | $126M | 57.42% | The filing omitted confidential holdings, a later amendment may add them. | |||
| NMFCNEW MTN FIN CORP | 3,345,088 | $48.8M | 22.25% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| BELLEROPHON THERAPEUTICS INCBELLEROPHON THERAPEUTICS INC | 4,859,885 | $44.6M | 20.33% | The filing omitted confidential holdings, a later amendment may add them. |
How Q1 2015 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-15-001220 | base | 2015-05-15 | acceptance time not in the bulk data set |